Thursday, January 17 – Lung Cancer Alliance joins a long list of leading patient advocacy groups in support of American Cancer Society Cancer Action Network’s (ASC CAN) advertising campaign, urging the U.S. Administration and Congress not to limit patient access to lifesaving medications covered under Medicare, and to ensure the Six Protected Classes policy is preserved.
The Six Protected Classes policy offers patients access to cutting-edge FDA-approved therapies for epilepsy, mental illness, cancer, HIV-Aids and organ transplants. A proposal from the administration could interfere with what doctors think is the best course of treatment for their patients and, if finalized, could delay patients’ access to lifesaving innovative therapies.
The ad will be featured in the following media outlets starting on Thursday, January 17: The Washington Post, The New York Times, The Hill, Roll Call and Politico.
To view the formal press release click here.